Поиск | Net Pals

Alexa добавлена новая статья Другое
2026-11-03 05:56:36 - Перевод -

Diabetic Ketoacidosis Treatment Market Set to Hit USD 1.46 Billion by 2036, Featuring Novo Nordisk, Eli Lilly and Sanofi
The global diabetic ketoacidosis treatment market is projected to increase from USD 940.5 million in 2026 to USD 1.46 billion by 2036, registering a compound annual growth rate (CAGR) of 4.5% during the forecast period, according to Fact.MR. The market was valued at USD 900 million in 2025. Demand is supported by rising disease prevalence, improved diagnosis rates and expanding access to...

0 Комментарии 0 Поделились 36 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
abhi2210 добавлена новая статья Health
2026-09-09 11:56:16 - Перевод -

Sarclisa Escena FDA Approval: Sanofi Transforms Multiple Myeloma Treatment Delivery
Sanofi has reached an important milestone in multiple myeloma management with the U.S. approval of Sarclisa Escena, a subcutaneous formulation of isatuximab-irfc administered using the CirCLIQ on-body injector. The U.S. Food and Drug Administration granted approval on July 9, 2026, marking the first anticancer therapy cleared for administration through an on-body injector. This development...

0 Комментарии 0 Поделились 507 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Subhayan2 добавлена новая статья Другое
2026-06-20 08:53:36 - Перевод -

Global Recombinant Human Insulin Market Growing at 5.6% CAGR Through 2034
According to a new report from Intel Market Research, the global Recombinant Human Insulin market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 9.7 billion by 2034, exhibiting a steady CAGR of 5.6% during the forecast period (2026–2034). This growth is driven by the rising prevalence of diabetes globally, advancements in...

0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!